Discord Remains On EU Clinical Trials Transparency, Even Within Industry
This article was originally published in The Pink Sheet Daily
Executive Summary
EU regulators, industry and researchers remain at odds on the level of transparency needed in clinical trials, despite a fast approaching deadline and efforts by EFPIA and PhRMA to break the diplomatic logjam.